EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production

Giorgia Palladini iD, Valentina Lepera iD, Serena Trubini, Gabriella Tocci, Andrea Zappavigna, Elizabeth Iskandar iD, Guglielmo Ferrari, Anna Prigitano iD, Nicola Ferraro, Roberta Schiavo, Fausto Baldanti, Caterina Cavanna und 1 weitere

Mycoses · 2025

DOI: 10.1111/myc.70111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Giorgia Palladini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Microbiology Unit, AUSL Piacenza, Piacenza, Italy. Hauptthemen laut MEDLINE: Candida parapsilosis, Drug Resistance, Fungal, Sterol 14-Demethylase, Cross Infection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Starting from 2018 onwards, several outbreaks of fluconazole‐resistant C. parapsilosis have been reported in many countries worldwide.

Objectives

Here we report a retrospective study on C. parapsilosis blood isolates collected over 7 years (2018–2024) in two hospitals in Northern Italy. Patients/Methods The study involved 169 C. parapsilosis isolates collected from individual hospitalised patients. We assessed the antifungal susceptibility of the isolates, evaluated the presence of mutations in the ERG11 gene and performed multilocus microsatellite typing to highlight the genetic relatedness of the strains. All isolates were also tested for their ability to produce biofilm.

Results

Among the 169 clinical isolates, 124 (73.4%) were classified as fluconazole‐resistant C. parapsilosis (FRCP) and 45 (26.6%) as fluconazole‐susceptible (FSCP). ERG11 sequencing highlighted that the most frequent mutation in FRCP is the Y132F (118/124, 95.2%). None of the FSCP carried the Y132F. Microsatellite genotyping showed five major clusters and 13 sub‐clusters, formed by isolates sharing identical genotypes. Sub‐cluster R1 included 96 FRCP carrying the Y132F substitution, isolated from 2018 to 2024 in both hospitals. Interestingly, 99.1% of the FRCP carrying the Y132F mutation were categorised as low biofilm formers, while FRCP carrying other ERG11 mutations were categorised as medium or high biofilm formers.

Conclusions

Our results confirmed that Y132F may be mainly responsible for azole resistance in C. parapsilosis and inter‐hospital spread. As we found, recent clinical studies indicate that FRCP isolates responsible for severe outbreaks produce thin biofilms. Mutated and therefore resistant strains may exhibit reduced biofilm production as a protective mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida parapsilosisDrug Resistance, FungalSterol 14-DemethylaseCross InfectionCandidiasisAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedAntifungal AgentsBiofilmsFluconazoleGenotyping TechniquesItalyMicrobial Sensitivity TestsMicrosatellite RepeatsRetrospective StudiesHospitals

Stichwörter der Autor:innen

C. parapsilosisERG11ItalyY132Fbiofilmfluconazole resistance

Substanzen

Antifungal AgentsFluconazoleSterol 14-Demethylase

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Microbiology Unit, AUSL Piacenza, Piacenza, Italy.
  • Department of Oncology-Hematology, AUSL Piacenza, Piacenza, Italy.
  • Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • National PhD Programme in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.
  • Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy.
  • Department of Clinical-Surgical, Diagnostic and Paediatric Sciences, Unit of Anaesthesia and Intensive Care, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

ORCID-Profile: Giorgia Palladini, Valentina Lepera, Elizabeth Iskandar, Anna Prigitano

Förderung

  • Ministero della Salute

Zitieren

APA

Palladini, G., Lepera, V., Trubini, S., Tocci, G., Zappavigna, A., Iskandar, E., Ferrari, G., Prigitano, A., Ferraro, N., Schiavo, R., Baldanti, F., Cavanna, C., & Lo Cascio, G. (2025). Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production. Mycoses. https://doi.org/10.1111/myc.70111

Vancouver

Palladini G, Lepera V, Trubini S, Tocci G, Zappavigna A, Iskandar E, et al. Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production. Mycoses. 2025. doi:10.1111/myc.70111

BibTeX
@article{Palladini2025,
  author = {Palladini, Giorgia and Lepera, Valentina and Trubini, Serena and Tocci, Gabriella and Zappavigna, Andrea and Iskandar, Elizabeth and Ferrari, Guglielmo and Prigitano, Anna and Ferraro, Nicola and Schiavo, Roberta and Baldanti, Fausto and Cavanna, Caterina and Lo Cascio, Giuliana},
  title = {Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production},
  journal = {Mycoses},
  year = {2025},
  doi = {10.1111/myc.70111}
}
Kostenlos starten →